Observatory of ATTR amyloidosis and of patients treated with Vyndaqel® (tafamidis) OBSAMYL study

First published 09/07/2018

Last updated 23/04/2024

EU PAS number:

EUPAS24718

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

OBSAMYL_protocole v3.0_20180329_VF

English (1.4 MB - PDF)View document

Study results

Study results

Summary_results_V6.6 rapport_20201014

English (92.39 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Signed checklist for study protocols

PFE Scan

English (371.91 KB - PDF)View document